ARTICLE | Distillery Therapeutics
Therapeutics: Nuclear receptor coactivator 3 (NCOA3; SRC3; AIB1)
April 21, 2016 7:00 AM UTC
In vitro testing, cell culture and mouse studies identified a small molecule inhibitor of NCOA3 that could help treat triple-negative breast cancer (TNBC). Screening of a small molecule library, in vi...